|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Lenalidomideinduces long-lasting responses in elderly patients with chronic lymphoeyticleukemia显示文摘 | STRATI P KEATING MJ WIERDA WG | 2013 | Blood2013，122，5： | 1 |
| 2 | CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia显示文摘 | Wierda WG Gantwell MJ Woods SJ | 2000 | Blood2000，96，： | 1 |
| 3 | CXCR4 is a prognostic marker in acute myelogenous leukemia显示文摘 | Spoo AC Lubbert M Wierda WG | | 0，，： | 1 |
| 4 | Immune anemias in patients with chronic lymphocytic treated with Fludarabine, cyclophosphamide and rituximab显示文摘 | Borhtakur G O' Brien S Wierda WG | 2006 | ASCO2006，，： | 1 |
| 5 | Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab-incidence and predictors 显示文摘 | Borthakur G OBrien S Wierda WG | 2007 | Br J Haematol2007，136，6： | 1 |
| 6 | Gossypol, a BH3 mimetic,induces apoptosis in chronic lymphocytic leukemia cells显示文摘 | Balakrishnan K Wierda WG Keating MJ | 2008 | Blood2008，112，5： | 1 |
| 7 | Chronic lymphocytic leukemia:new concept for future therapy显示文摘 | Wierda WG Chiorazzi N Dearden C | | 0，，05： | 1 |
| 8 | Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab-ineidence and predictors显示文摘 | Borthakur G O'Brien S Wierda WG | 2007 | Br J Haematol2007，136，6： | 1 |
| 9 | Immune ananmias in patients with chronic lymphocytic leukaemia treated with fludarab ine,cycloophosphamide and rituximab incidence and predictors显示文摘 | Borthakur GO Brien S Wierda WG | | 0，，06： | 1 |
| 10 | Ofatumumab as singleagent CD20 immunotherapy in fludarabine-refractory chronic lymphocytic leukemia 显示文摘 | Wierda WG Kipps T J Mayer J | 2010 | J Clin Oncol2010，28，10： | 1 |
| 11 | Gossypol, a BH3 mimetic, induces apoptosis in chronic lymphocytic leukemia ceils 显示文摘 | Balakrishnan K Wierda WG Keating M J | 2008 | Blood2008，112，5： | 1 |
| 12 | Non-Hodgkin' s lymphomas, version 4,2014显示文摘 | Zelenetz AD Gordon LI Wierda WG | 2014 | J Natl Compr Canc Netw2014，12，9： | 1 |
| 13 | Genetics and molecular biology of chronic lymphocytic leukemia显示文摘 | Carney DA Wierda WG | 2005 | Curr Treat Options Oncol2005，6，3： | 1 |
| 14 | CXCR4 is a prognostic marker in acute myelogenous leukemia 显示文摘 | Spoo AC Lubbert M Wierda WG | 2007 | Blood2007，109，2： | 1 |
| 15 | Gossypol, a BH3 mimetic, induces apoptosis in chronic lymphocytic leukemia cells 显示文摘 | Balakrishnan K Wierda WG Keating M J | 2008 | Blood2008，112，5： | 1 |
| 16 | Chemoim-munotherapy with O-FC in previously untreated patients with chronic lymphocytic leukemia显示文摘 | Wierda WG Kipps TJ Durig J | 2011 | Blood2011，117，24： | 1 |
| 17 | Ofatumumab as single-agent CD20 immunotherapy in fludarabine-refractory chronic lymphocytic leukemia显示文摘 | Wierda WG Kipps TJ Mayer J | 2010 | J Clin Oncol2010，28，10： | 1 |
| 18 | Safety and activity of Ibrutinib plus Rituximab for patients with high-risk chronic lymphocytic leukaemia: A single-arm, phase 2 study显示文摘 | Burger JA Keating MJ Wierda WG | 2014 | Lancet Oncol2014，15，10： | 1 |
| 19 | Immune anaemias in patientswith chronic lymphocytic leukaemia treated with fludara-bine,cyclophosphamide and rituximab-incidence and predictors显示文摘 | Borthakur G OB′rien S Wierda WG | 2007 | Br J Haematol2007，136，6： | 1 |
| 20 | Chemoimmunotherapy with O-FCin previously untreated patients with chronic lymphocytic leukemia 显示文摘 | Wierda WG Kipps TJ DurigJ | 2011 | Blood2011，117，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员